|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-6-8
|
|
pubmed:abstractText |
Immunoglobulin-related free light chains (FLCs) in serum have recently become quantitatively detectable using the nephelometric assay in plasma cell disorders, including multiple myeloma and AL amyloidosis. To investigate whether FLCs are useful as a diagnostic and therapeutic marker in Japanese patients with primary systemic AL amyloidosis, we determined these values in serum before and after chemotherapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Light Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin kappa-Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin lambda-Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Melphalan,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloma Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/multiple myeloma M-proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0918-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
428-33
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15942088-Adult,
pubmed-meshheading:15942088-Aged,
pubmed-meshheading:15942088-Amyloidosis,
pubmed-meshheading:15942088-Antineoplastic Agents, Alkylating,
pubmed-meshheading:15942088-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15942088-Biological Markers,
pubmed-meshheading:15942088-Biopsy,
pubmed-meshheading:15942088-Dexamethasone,
pubmed-meshheading:15942088-Dose-Response Relationship, Drug,
pubmed-meshheading:15942088-Doxorubicin,
pubmed-meshheading:15942088-Female,
pubmed-meshheading:15942088-Humans,
pubmed-meshheading:15942088-Immunoassay,
pubmed-meshheading:15942088-Immunoglobulin Light Chains,
pubmed-meshheading:15942088-Immunoglobulin kappa-Chains,
pubmed-meshheading:15942088-Immunoglobulin lambda-Chains,
pubmed-meshheading:15942088-Incidence,
pubmed-meshheading:15942088-Infusions, Intravenous,
pubmed-meshheading:15942088-Intestinal Mucosa,
pubmed-meshheading:15942088-Japan,
pubmed-meshheading:15942088-Kidney,
pubmed-meshheading:15942088-Male,
pubmed-meshheading:15942088-Melphalan,
pubmed-meshheading:15942088-Middle Aged,
pubmed-meshheading:15942088-Myeloma Proteins,
pubmed-meshheading:15942088-Nephelometry and Turbidimetry,
pubmed-meshheading:15942088-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:15942088-Retrospective Studies,
pubmed-meshheading:15942088-Treatment Outcome,
pubmed-meshheading:15942088-Vincristine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.
|
|
pubmed:affiliation |
Third Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
